FAILED
首站-论文投稿智能助手
典型文献
Network pharmacology and molecular docking study on the effect of Kaempferol in treatment of metabolic associated fatty liver disease
文献摘要:
OBJECTIVE:To study therapeutic effect of kaempferol on metabolic associated fatty liver disease(MAFLD)by network pharmacology and molecular docking combined with cell experiments.METHODS:First,use the SwissTargetPrediction database to predict the targets of kaempferol,and collect the targets of MAFLD through the Disgenet database and the GeneCards database.Then,the common target of kaempferol and MAFLD was enriched and analyzed by the Gene Ontology(GO)and Kyoto Encyclopedia of Genes and Genomes,and the protein-protein interaction(PPI)network was constructed through the string database to obtain the key targets,and carry out molecular docking of key targets with kaempferol;In cell experiment,oleic acid induced steatosis in HepG2 cells,which was intervened by kaempferol,the level of triglyceride(TG)was detected,the lipid deposition was observed by oil red O staining,and the protein expression was detected by Western blot.RESULTS:The results showed that there are 33 common targets for kaempferol and MAFLD.The biological process of GO is related to the regulation of protein kinase B,cell apoptosis,inflammatory factors,lipoxygenase,etc.Its action pathway is related to the phosphatidylinositol-3-kinase and protein kinase B(PI3K-AKT)signaling pathway,hypoxia-inducible factor 1 signaling pathway,forkhead box protein O signaling pathway,AMP-activated protein kinase signaling pathway,tumor necrosis factor signaling pathway,etc.,the key targets are protein kinase B(AKT1),pros-taglandin G/H synthase 2,matrix metalloproteinase-9,epidermal growth factor receptor,and the molecular docking of kaempferol with the four key targets shows good binding properties.Cell experiments show that kaempferol can reduce cell TG levels,reduce lipid deposition,increase the expression of PI3K,AKT,and beclin-1,and reduce the expression of caspase-3 and nuclear factor-kappa B.Kaempferol can treat MAFLD by regulating the PI3K-AKT signaling pathway to regulate cell autophagy,apoptosis,and inflammation.CONCLUSIONS:This study shows that kaempferol can regulate lipid metabolism,reduce apoptosis,regulate inflammation and autophagy in the fatty liver cell model.It reveals the therapeutic mechanism of kaempferol on MAFLD and provides a natural product candidate for the treatment of MAFLD.
文献关键词:
作者姓名:
ZHOU Kaixuan;ZHANG Dong;BAO Huiwei;LI Lijing
作者机构:
College of Pharmacy,Changchun University of Chinese Medicine,Changchun 130117,China
引用格式:
[1]ZHOU Kaixuan;ZHANG Dong;BAO Huiwei;LI Lijing-.Network pharmacology and molecular docking study on the effect of Kaempferol in treatment of metabolic associated fatty liver disease)[J].中医杂志(英文版),2022(05):788-794
A类:
taglandin
B类:
Network,pharmacology,molecular,docking,study,effect,Kaempferol,treatment,metabolic,associated,fatty,liver,disease,OBJECTIVE,To,therapeutic,kaempferol,MAFLD,by,network,combined,experiments,METHODS,First,use,SwissTargetPrediction,database,predict,targets,collect,through,Disgenet,GeneCards,Then,common,was,enriched,analyzed,Ontology,Kyoto,Encyclopedia,Genes,Genomes,interaction,PPI,constructed,string,obtain,key,carry,out,In,oleic,acid,induced,steatosis,HepG2,cells,which,intervened,triglyceride,detected,lipid,deposition,observed,oil,staining,expression,blot,RESULTS,results,showed,that,there,are,biological,process,related,regulation,kinase,apoptosis,inflammatory,factors,lipoxygenase,etc,Its,pathway,phosphatidylinositol,PI3K,signaling,hypoxia,inducible,forkhead,box,AMP,activated,tumor,necrosis,AKT1,pros,synthase,matrix,metalloproteinase,epidermal,growth,receptor,four,shows,good,binding,properties,Cell,reduce,levels,increase,beclin,caspase,nuclear,kappa,regulating,regulate,autophagy,inflammation,CONCLUSIONS,This,metabolism,model,reveals,mechanism,provides,natural,product,candidate
AB值:
0.450398
相似文献
Globular adiponectin-mediated vascular remodeling by affecting the secretion of adventitial-derived tumor necrosis factor-αinduced by urotensin Ⅱ
Jun LI;Limin LUO;Yonggang ZHANG;Xiao DONG;Shuyi DANG;Xiaogang GUO;Wenhui DING-Department of Cardiology,the First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China;Division of Cardiology,Department of Internal Medicine,Taihe Hospital,Hubei University of Medicine,Shiyan 442000,China;Division of Cardiology,Department of Internal Medicine,Peking University First Hospital,Beijing 100034,China;Department of Dermatology,the First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China;Department of Cardiovascular Diseases,the Second Affiliated Hospital,Shantou University Medical College,Shantou 515041,China
Integrated UHPLC-MS and network pharmacology to explore the active constituents and pharmacological mechanisms of Shenzao dripping pills against coronary heart disease
Tao Hu;Ke-Ning Zheng;Jia-Yin Liang;Dan Tang;Lu-Yong Zhang;Ming-Hua Xian;Shu-Mei Wang-Key Laboratory of Digital Quality Evaluation of Chinese Materia Medica of State Administration of Traditional Chinese Medicine,Guangdong Pharmaceutical University,Guangzhou 510006,China;Engineering&Technology Research Center for Chinese Materia Medica Quality of the Universities of Guangdong Province,Guangzhou 510006,China;School of Traditional Chinese Medicine,Guangdong Pharmaceutical University,Guangzhou 510006,China;Guangzhou Key Laboratory of Construction and Application of New Drug Screening Model Systems,Guangdong Pharmaceutical University,Guangzhou 510006,China;School of Pharmacy,Guangdong Pharmaceutical University,Guangzhou 510006,China
Antrodia cinnamomea exerts an anti-hepatoma effect by targeting PI3K/AKT-mediated cell cycle progression in vitro and in vivo
Yan Zhang;Pin Lv;Junmei Ma;Ning Chen;Huishan Guo;Yan Chen;Xiaoruo Gan;Rong Wang;Xuqiang Liu;Sufang Fan;Bin Cong;Wenyi Kang-Hebei Key Laboratory of Forensic Medicine,College of Forensic Medicine,Hebei Medical University,Shijiazhuang 050017,China;Hebei Food Safety Key Laboratory,Hebei Food Inspection and Research Institute,Shijiazhuang 050091,China;Cardiovascular Medical Science Center Department of Cell Biology,Hebei Medical University,Shijiazhuang 050017,China;National R&D Center for Edible Fungus Processing Technology,Henan University,Kaifeng 475004,China;Research Unit of Digestive Tract Microecosystem Pharmacology and Toxicology,Chinese Academy of Medical Sciences,Beijing 100730,China
Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo
Fanxiang Yin;Ran Zhao;Dhilli Rao Gorja;Xiaorong Fu;Ning Lu;Hai Huang;Beibei Xu;Hanyong Chen;Jung-Hyun Shim;Kangdong Liu;Zhi Li;Kyle Vaughn Laster;Zigang Dong;Mee-Hyun Lee-Department of Pathophysiology,School of Basic Medical Sciences,Zhengzhou University,Zhengzhou 450001,China;China-US(Henan)Hormel Cancer Institute,Zhengzhou 450008,China;Translational Medical Center,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;The Hormel Institute,University of Minnesota,Austin,MN 55912,USA;Department of Biomedicine,Health&Life Convergencen Science,BK21 Four,College of Pharmacy,Mokpo National University,Jeonnam 58554,Republic of Korea;The Collaborative Innovation Center of Henan Province for Cancer Chemoprevention,Zhengzhou 450001,China;Department of General Surgery,the Affiliated Tumor Hospital of Zhengzhou University,Zhengzhou 450008,China;College of Korean Medicine,Dongshin University,Naju 58245,Republic of Korea
Sulforaphane ameliorates non-alcoholic fatty liver disease in mice by promoting FGF21/FGFR1 signaling pathway
Yi-kuan Wu;Zheng-nan Ren;Sheng-long Zhu;Yun-zhou Wu;Gang Wang;Hao Zhang;Wei Chen;Zhao He;Xian-long Ye;Qi-xiao Zhai-State Key Laboratory of Food Science and Technology,Jiangnan University,Wuxi 214122,China;School of Food Science and Technology,Jiangnan University,Wuxi 214122,China;School of Medicine,Jiangnan University,Wuxi 214122,China;College of Life Science,Northeast Agricultural University,Harbin 150038,China;National Engineering Research Center for Functional Food,Jiangnan University,Wuxi 214122,China;Shandong Key Laboratory of Endocrinology and Lipid Metabolism,Jinan 250021,China;School of Medicine,Shandong University,Jinan 250012,China;Ganjiang Chinese Medicine Innovation Center,Nanchang 330000,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。